United Therapeutics

TYVASO - Cost

Last Updated: April 1st, 2024

HCPCS:

J7686

HCPCS Code Descriptor:

Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg

Medicare Payment Limit:

The TYVASO Medicare Payment Limit is $725.266

Average Sale Price:

TYVASO ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The TYVASO Medicare Co-insurance percentage is 20%. TYVASO's Medicare Co-insurance amount is $145.05 per HCPCS unit.

APC Code:

The Tyvaso APC Code is: not available

APC Payment Limit:

The APC Payment Limit for TYVASO is not available.

Tyvaso Cost Information:

Tyvaso’s J Code, J7686, was added and made effective in January of 2011. Since the J7686 HCPCS has been effective, Tyvaso has taken roughly annual increases to its WAC and AWP list prices. Tyvaso’s ASP has remained close to its WAC, indicating a lack of discounting by the manufacturer, United Therapeutics.

ACCESS PRICING AND MORE BY REGISTERING

Tyvaso’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Tyvaso’s average wholesale price (AWP) information was last updated on:
January 1, 2024